Compare BDTX & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | BGH |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 286.7M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | BGH |
|---|---|---|
| Price | $2.40 | $13.70 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.20 | N/A |
| AVG Volume (30 Days) | ★ 605.0K | 75.9K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.13 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $12.52 |
| 52 Week High | $4.94 | $16.90 |
| Indicator | BDTX | BGH |
|---|---|---|
| Relative Strength Index (RSI) | 58.24 | 42.14 |
| Support Level | $2.20 | N/A |
| Resistance Level | $2.86 | $15.27 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 79.59 | 59.74 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.